Legumain expression, activity and secretion are increased during monocyte-to-macrophage differentiation and inhibited by atorvastatin

References

Alvarez-Fernandez, M., Barrett, A.J., Gerhartz, B., Dando, P.M., Ni, J.A., and Abrahamson, M. (1999). Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site. J. Biol. Chem. 274, 19195–19203.10.1074/jbc.274.27.19195Search in Google Scholar

Auwerx, J. (1991). The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. Experientia 47, 22–31.10.1007/BF02041244Search in Google Scholar

Barrett, A.J. and Kirschke, H. (1981). Cathepsin B, cathepsin H, and cathepsin L. Methods Enzymol. 80, 535–561.10.1016/S0076-6879(81)80043-2Search in Google Scholar

Berven, L., Johansen, H.T., Solberg, R., Kolset, S.O., and Samuelsen, A.B.C. (2013a). Autoactivation of prolegumain is accelerated by glycosaminoglycans. Biochimie 95, 772–781.10.1016/j.biochi.2012.11.002Search in Google Scholar

Berven, L., Solberg, R., Truong, H.H.T., Arlov, Ø., Lillelund Aachmann, F., Skjåk-Bræk, G., Egge-Jacobsen, W.M., Thidemann Johansen, H., and Samuelsen, A.B.C. (2013b). Alginates induce legumain activity in RAW 264.7 cells and accelerate autoactivation of prolegumain. Bioact. Carbohydr. Dietary Fibre 2, 30–44.10.1016/j.bcdf.2013.08.003Search in Google Scholar

Bradford, M.M. (1976). Rapid and sensitive method for quantitation of microgram quantities of protein utilizing principle of protein-dye binding. Anal. Biochem. 72, 248–254.10.1016/0003-2697(76)90527-3Search in Google Scholar

Chan, C.B., Abe, M., Hashimoto, N., Hao, C., Williams, I.R., Liu, X., Nakao, S., Yamamoto, A., Li, S.Y., Asano, M., et al. (2009). Mice lacking asparaginyl endopeptidase develop disorders resembling hemophagocytic syndrome. Proc. Natl. Acad. Sci. USA 106, 468–473.10.1073/pnas.0809824105Search in Google Scholar

Chen, J.M., Dando, P.M., Rawlings, N.D., Brown, M.A., Young, N.E., Stevens, R.A., Hewitt, E., Watts, C., and Barrett, A.J. (1997). Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase. J. Biol. Chem.272, 8090–8098.10.1074/jbc.272.12.8090Search in Google Scholar

Chen, J.M., Rawlings, N.D., Stevens, R.A.E., and Barrett, A.J. (1998a). Identification of the active site of legumain links it to caspases, clostripain and gingipains in a new clan of cysteine endopeptidases. FEBS Lett. 441, 361–365.10.1016/S0014-5793(98)01574-9Search in Google Scholar

Chen, J.M., Dando, P.M., Stevens, R.A.E., Fortunato, M., and Barrett, A.J. (1998b). Cloning and expression of mouse legumain, a lysosomal endopeptidase. Biochem. J. 335, 111–117.10.1042/bj3350111Search in Google Scholar PubMed PubMed Central

Chen, J.M., Fortunato, M., Stevens, R.A.E., and Barrett, A.J. (2001). Activation of progelatinase A by mammalian legumain, a recently discovered cysteine proteinase. Biol. Chem. 382, 777–783.10.1515/bchm.2001.382.5.777Search in Google Scholar

Choi, S.J., Reddy, S.V., Devlin, R.D., Menaa, C., Chung, H.Y., Boyce, B.F., and Roodman, G.D. (1999). Identification of human asparaginyl endopeptidase (legumain) as an inhibitor of osteoclast formation and bone resorption. J. Biol. Chem.274, 27747–27753.10.1074/jbc.274.39.27747Search in Google Scholar

Clerin, V., Shih, H.H., Deng, N., Hebert, G., Resmini, C., Shields, K.M., Feldman, J.L., Winkler, A., Albert, L., Maganti, V., et al. (2008). Expression of the cysteine protease legumain in vascular lesions and functional implications in atherogenesis. Atherosclerosis 201, 53–66.10.1016/j.atherosclerosis.2008.01.016Search in Google Scholar

Dall, E. and Brandstetter, H. (2013). Mechanistic and structural studies on legumain explain its zymogenicity, distinct activation pathways, and regulation. Proc. Natl. Acad. Sci. USA 110, 10940–10945.10.1073/pnas.1300686110Search in Google Scholar

Edgington, L.E., Verdoes, M., Ortega, A., Withana, N.P., Lee, J., Syed, S., Bachmann, M.H., Blum, G., and Bogyo, M. (2013). Functional imaging of legumain in cancer using a new quenched activity-based probe. J. Am. Chem. Soc. 135, 174–182.10.1021/ja307083bSearch in Google Scholar

Halfon, S., Patel, S., Vega, F., Zurawski, S., and Zurawski, G. (1998). Autocatalytic activation of human legumain at aspartic acid residues. FEBS Lett. 438, 114–118.10.1016/S0014-5793(98)01281-2Search in Google Scholar

Hashimoto, S., Suzuki, T., Dong, H.Y., Nagai, S., Yamazaki, N., and Matsushima, K. (1999). Serial analysis of gene expression in human monocyte-derived dendritic cells. Blood 94, 845–852.10.1182/blood.V94.3.845.415k09_845_852Search in Google Scholar

Huh, H.Y., Pearce, S.F., Yesner, L.M., Schindler, J.L., and Silverstein, R.L. (1996). Regulated expression of CD36 during monocyte-to-macrophage differentiation: Potential role of CD36 in foam cell formation. Blood 87, 2020–2028.10.1182/blood.V87.5.2020.2020Search in Google Scholar

Johansen, H.T., Knight, C.G., and Barrett, A.J. (1999). Colorimetric and fluorimetric microplate assays for legumain and a staining reaction for detection of the enzyme after electrophoresis. Anal. Biochem. 273, 278–283.10.1006/abio.1999.4221Search in Google Scholar PubMed

Larsen, S., Stride, N., Hey-Mogensen, M., Hansen, C.N., Bang, L.E., Bundgaard, H., Nielsen, L.B., Helge, J.W., and Dela, F. (2013). Simvastatin effects on skeletal muscle relation to decreased mitochondrial function and glucose intolerance. J. Am. Coll. Cardiol. 61, 44–53.10.1016/j.jacc.2012.09.036Search in Google Scholar PubMed

Li, D.N., Matthews, S.P., Antoniou, A.N., Mazzeo, D., and Watts, C. (2003). Multistep autoactivation of asparaginyl endopeptidase in vitro and in vivo. J. Biol. Chem. 278, 38980–38990.10.1074/jbc.M305930200Search in Google Scholar PubMed

Liao, J.K. and Laufs, U. (2005). Pleiotropic effects of statins. Ann. Rev. Pharmacol. Toxicol. 45, 89–118.10.1146/annurev.pharmtox.45.120403.095748Search in Google Scholar PubMed PubMed Central

Lin, Y., Wei, C., Liu, Y., Qiu, Y., Liu, C., and Guo, F. (2013). Selective ablation of tumor-associated macrophages suppresses metastasis and angiogenesis. Cancer Sci. 104, 1217–1225.10.1111/cas.12202Search in Google Scholar PubMed PubMed Central

Liu, C., Sun, C.Z., Huang, H.N., Janda, K., and Edgington, T. (2003). Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy. Cancer Res. 63, 2957–2964.Search in Google Scholar

Luo, Y., Zhou, H., Krueger, J., Kaplan, C., Lee, S.H., Dolman, C., Markowitz, D., Wu, W., Liu, C., Reisfeld, R.A., et al. (2006). Targeting tumor-associated macrophages as a novel strategy against breast cancer. J. Clin. Invest. 116, 2132–2141.10.1172/JCI27648Search in Google Scholar PubMed PubMed Central

Manoury, B., Hewitt, E.W., Morrice, N., Dando, P.M., Barrett, A.J., and Watts, C. (1998). An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation. Nature 396, 695–699.10.1038/25379Search in Google Scholar PubMed

Marin, L., Colombo, P., Bebawy, M., Young, P.M., and Traini, D. (2011). Chronic obstructive pulmonary disease: patho-physiology, current methods of treatment and the potential for simvastatin in disease management. Exp. Opin. Drug Deliv. 8, 1205–1220.10.1517/17425247.2011.588697Search in Google Scholar PubMed

Mattock, K.L., Gough, P.J., Humphries, J., Burnand, K., Patel, L., Suckling, K.E., Cuello, F., Watts, C., Gautel, M., Avkiran, M., et al. (2010). Legumain and cathepsin-L expression in human unstable carotid plaque. Atherosclerosis 208, 83–89.10.1016/j.atherosclerosis.2009.07.022Search in Google Scholar PubMed

Miller, G., Matthews, S.P., Reinheckel, T., Fleming, S., and Watts, C. (2011). Asparagine endopeptidase is required for normal kidney physiology and homeostasis. FASEB J. 25, 1606–1617.10.1096/fj.10-172312Search in Google Scholar PubMed

Morita, Y., Araki, H., Sugimoto, T., Takeuchi, K., Yamane, T., Maeda, T., Yamamoto, Y., Nishi, K., Asano, M., Shirahama-Noda, K., et al. (2007). Legumain/asparaginyl endopeptidase controls extracellular matrix remodeling through the degradation of fibronectin in mouse renal proximal tubular cells. FEBS Lett. 581, 1417–1424.10.1016/j.febslet.2007.02.064Search in Google Scholar PubMed

Papaspyridonos, M., Smith, A., Burnand, K.G., Taylor, P., Padayachee, S., Suckling, K.E., James, C.H., Greaves, D.R., and Patel, L. (2006). Novel candidate genes in unstable areas of human atherosclerotic plaques. Arterioscl., Thromb. Vascul. Biol. 26, 1837–1844.10.1161/01.ATV.0000229695.68416.76Search in Google Scholar PubMed

Peres, C., Yart, A., Perret, B., Salles, J.P., and Raynal, P. (2003). Modulation of phosphoinositide 3-kinase activation by cholesterol level suggests a novel positive role for lipid rafts in lysophosphatidic acid signalling. FEBS Lett. 534, 164–168.10.1016/S0014-5793(02)03832-2Search in Google Scholar

Pike, L.J. and Miller, J.M. (1998). Cholesterol depletion delocalizes phosphatidylinositol bisphosphate and inhibits hormone-stimulated phosphatidylinositol turnover. J. Biol. Chem. 273, 22298–22304.10.1074/jbc.273.35.22298Search in Google Scholar PubMed

Qin, Z. (2012). The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature. Atherosclerosis 221, 2–11.10.1016/j.atherosclerosis.2011.09.003Search in Google Scholar PubMed

Schwende, H., Fitzke, E., Ambs, P., and Dieter, P. (1996). Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3. J. Leukocyte Biol. 59, 555–561.10.1002/jlb.59.4.555Search in Google Scholar

Sepulveda, F.E., Maschalidi, S., Colisson, R., Heslop, L., Ghirelli, C., Sakka, E., Lennon-Duménil, A.M., Amigorena, S., Cabanie, L., and Manoury, B. (2009). Critical role for asparagine endopeptidase in endocytic Toll-like receptor signaling in dendritic cells. Immunity 31, 737–748.10.1016/j.immuni.2009.09.013Search in Google Scholar PubMed

Shirahama-Noda, K., Yamamoto, A., Sugihara, K., Hashimoto, N., Asano, M., Nishimura, M., and Hara-Nishimura, I. (2003). Biosynthetic processing of cathepsins and lysosomal degradation are abolished in asparaginyl endopeptidase-deficient mice. J. Biol. Chem. 278, 33194–33199.10.1074/jbc.M302742200Search in Google Scholar PubMed

Skottheim, I.B., Gedde-Dahl, A., Hejazifar, S., Hoel, K., and Åsberg, A. (2008). Statin induced myotoxicity: the lactone forms are more potent than the acid forms in human skeletal muscle cells in vitro. Eur. J. Pharmaceutical. Sci. 33, 317–325.10.1016/j.ejps.2007.12.009Search in Google Scholar PubMed

Slade, P.G., Hajivandi, M., Bartel, C.M., and Gorfien, S.F. (2012). Identifying the CHO secretome using mucin-type O-linked glycosylation and click-chemistry. J. Proteome Res. 11, 6175–6186.10.1021/pr300810fSearch in Google Scholar PubMed

Smith, R., Johansen, H.T., Nilsen, H., Haugen, M.H., Pettersen, S.J., Mælandsmo, G.M., Abrahamson, M., and Solberg, R. (2012). Intra- and extracellular regulation of activity and processing of legumain by cystatin E/M. Biochimie 94, 2590–2599.10.1016/j.biochi.2012.07.026Search in Google Scholar PubMed

Smith, R., Solberg, R., Jacobsen, L.L., Voreland, A.L., Rustan, A.C., Thoresen, G.H., and Johansen, H.T. (2014). Simvastatin inhibits glucose uptake and legumain activity in human myotubes. PLoS One 9, e85721.Search in Google Scholar

Subtil, A., Gaidarov, I., Kobylarz, K., Lampson, M.A., Keen, J.H., and McGraw, T.E. (1999). Acute cholesterol depletion inhibits clathrin-coated pit budding. Proc. Natl. Acad. Sci. USA 96, 6775–6780.10.1073/pnas.96.12.6775Search in Google Scholar PubMed PubMed Central

van der Meij, E., Koning, G.G., Vriens, P.W., Peeters, M.F., Meijer, C.A., Kortekaas, K.E., Dalman, R.L., van Bockel, J.H., Hanemaaijer, R., Kooistra, T., et al. (2013). A clinical evaluation of statin pleiotropy: statins selectively and dose-dependently reduce vascular inflammation. PLoS One 8(1):e53882.Search in Google Scholar

Wang, Z.H., Liu, X.L., Zhong, M., Zhang, L.P., Shang, Y.Y., Hu, X.Y., Li, L., Zhang, Y., Deng, J.T., and Zhang, W. (2010). Pleiotropic effects of atorvastatin on monocytes in atherosclerotic patients. J. Clin. Pharmacol. 50, 311–319.10.1177/0091270009340889Search in Google Scholar PubMed

Werle, B., Ebert, W., Klein, W., and Spiess, E. (1995). Assessment of cathepsin-L activity by use of the inhibitor Ca-074 compared to cathepsin-B activity in human lung tumor-tissue. Bio. Chem. Hoppe-Seyler 376, 157–164.10.1515/bchm3.1995.376.3.157Search in Google Scholar PubMed

Zeeuwen, P. (2004). Epidermal differentiation: the role of proteases and their inhibitors. Eur. J. Cell Biol. 83, 761–773.10.1078/0171-9335-00388Search in Google Scholar PubMed

Zhao, L., Hua, T., Crowley, C., Ru, H., Ni, X., Shaw, N., Jiao, L., Ding, W., Qu, L., Hung, L.W., et al. (2014). Structural analysis of asparaginyl endopeptidase reveals the activation mechanism and a reversible intermediate maturation stage. Cell Res. 24, 344–358.10.1038/cr.2014.4Search in Google Scholar PubMed PubMed Central

Supplemental Material: The online version of this article (DOI: 10.1515/hsz-2014-0172) offers supplementary material, available to authorized users.Search in Google Scholar